Exposure to Rosiglitazone and Fluoxetine in the First Trimester of Pregnancy

  • CHOI, JUNE-SEEK MD
  • HAN, JUNG-YEOL MD
  • AHN, HYUN-KYONG MD
  • SHIN, JOONG-SIK MD
  • YANG, JAE-HYUG MD
  • KOONG, MI-KYOUNG MD
  • NAVA-OCAMPO, ALEJANDRO A. MD

  • 1Korean Motherisk Program, Cheil Hospital and Women's Health Care Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    2Division of Maternal Fetal Medicine, Cheil Hospital and Women's Health Care Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    3Division of Infertlilty, Department of Obstetrics and Gynecology, Cheil Hospital and Women's Health Care Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    4Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada

Address correspondence to Dr. Jung-Yeol Han, The Korean Motherisk Program, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Cheil Hospital, Sungkyunkwan University, School of Medicine, 1-19 Mookjung-Dong, Choong-Gu, Seoul 100-380, Korea. E-mail: [email protected]

Diabetes Care 29(9):p 2176, September 2006.
Copyright © 2006 by the American Diabetes Association, Inc.